RAMP 202: A phase 2 study of avutometinib (VS-6766) +- defactinib, in patients with advanced KRAS G12V mutant non-small cell lung cancer (NSCLC).
Avutometinib;Defactinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: RAMP 202: A phase 2 study of avutometinib (VS-6766) +- defactinib, in patients with advanced KRAS G12V mutant non-small cell lung cancer (NSCLC). ### Output: Avutometinib;Defactinib